Eone Diagnomics Genome Center, Co, Ltd
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Eone Diagnomics Genome Center, Co, Ltd - overview
Established
2013
Location
Incheon, -, South Korea
Primary Industry
Biotechnology
About
Founded in 2013 and based in Incheon, South Korea, Eone Diagnomics Genome Center, Co, Ltd provides genome analytics services for cancer-centric medicines and genetic diseases.
Current Investors
Korea Securities Finance Corporation, Blue Corner, Kolmar Korea
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy, Bioinformatics, Diagnostic, Medical & Imaging Laboratories, Oncology/Cancer Treatment
Website
www.edgc.com
Company Stage
Mature
Total Amount Raised
Subscriber access only
Eone Diagnomics Genome Center, Co, Ltd - timeline of key events
Eone Diagnomics Genome Center, Co, Ltd - financials
| Fiscal Year Ended | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | Dec 31, 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | 1,393,005,758 | 3,234,750,458 | 21,496,787,319 | 56,721,869,566 | 92,541,208,930 | 89,282,114,475 | 94,243,692,888 | - | - | - |
| % Revenue Growth (YoY) | - | 132.2% | 564.6% | 163.9% | 63.1% | (3.5%) | 5.6% | - | - | - |
| EBITDA (USD) | (2,983,744,810) | (4,839,824,762) | (6,245,584,179) | (6,220,739,648) | 8,148,205,510 | (10,012,045,704) | (3,344,882,120) | - | - | - |
| Operating Income (USD) | (3,245,322,810) | (5,172,720,762) | (6,815,179,179) | (8,553,545,648) | 5,108,643,510 | (15,602,204,704) | (9,520,183,120) | - | - | - |
| Operating Margin | (233.0%) | (159.9%) | (31.7%) | (15.1%) | 5.5% | (17.5%) | (10.1%) | - | - | - |
| % EBITDA Margin | (214.2%) | (149.6%) | (29.1%) | (11.0%) | 8.8% | (11.2%) | (3.5%) | - | - | - |
| NET Income (USD) | (3,866,552,681) | (6,080,151,466) | (7,253,213,818) | (8,605,224,718) | (9,433,328,400) | (20,666,748,769) | (29,864,754,680) | - | - | - |
| % Net Margin | (277.6%) | (188.0%) | (33.7%) | (15.2%) | (10.2%) | (23.1%) | (31.7%) | - | - | - |
Eone Diagnomics Genome Center, Co, Ltd - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.